Correction to: Acta Pharmacologica Sinica https://doi.org/10.1038/s41401-021-00658-9, published online 13 April 2021
The author apologized that the Supplementary information of article 658 was not uploaded. The two Supplementary figures were listed below. The revisions do not affect any results and conclusions of the current work. The authors apologize for the inconvenience caused to the journal and readers.
(a) mRNA levels of PKM2 and HK2. (b) PKM2 protein expression in LX2 cells was detected by immunofluorescence. (c) mRNA levels of αSMA and COL1α1. (d) αSMA protein expression in LX2 cells was examined by immunofluorescence. Data are shown as the mean ± SD (n = 3) of one representative experiment; *P < 0.05, **P < 0.01 vs. control group; #P < 0.05, ##P < 0.01 vs. TGF-β1-stimulated group.
(a) Co-immunoprecipitation/Western blotting method.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/s41401-021-00658-9.
Rights and permissions
About this article
Cite this article
Xu, L., Yang, Ty., Zhou, Yw. et al. Author Correction: Bmal1 inhibits phenotypic transformation of hepatic stellate cells in liver fibrosis via IDH1/α-KG-mediated glycolysis. Acta Pharmacol Sin 43, 757–758 (2022). https://doi.org/10.1038/s41401-021-00685-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41401-021-00685-6
